Literature DB >> 18446376

Oral-ibuprofen-induced acute renal failure in a preterm infant.

Omer Erdeve1, S Umit Sarici, Erkan Sari, Faysal Gok.   

Abstract

The side effects of indomethacin for ductal closure in preterm neonates (e.g. increased incidence of necrotizing enterocolitis, decreased cerebral blood volume and transient renal failure) have led clinicians to seek a safer alternative. Intravenous indomethacin and ibuprofen appear to be equally effective for patent ductus arteriosus closure, but oral ibuprofen remains an experimental option with theoretical advantages yet with potential side effects. We herein report a case of transient but severe acute renal failure developing in a preterm infant in whom oral ibuprofen was used and discuss the safety of this drug in relation to its pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446376     DOI: 10.1007/s00467-008-0835-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates.

Authors:  Pramila Hariprasad; V Sundarrajan; G Srimathy; B Suthagar; B Shyla Ramadevi
Journal:  Indian Pediatr       Date:  2002-01       Impact factor: 1.411

Review 2.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  S S Shah; A Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 3.  A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.

Authors:  Ronald L Thomas; Graham C Parker; Bart Van Overmeire; Jacob V Aranda
Journal:  Eur J Pediatr       Date:  2004-12-10       Impact factor: 3.183

Review 4.  Systematic review: intravenous Ibuprofen in preterm newborns.

Authors:  J V Aranda; Ronald Thomas
Journal:  Semin Perinatol       Date:  2006-06       Impact factor: 3.300

Review 5.  Effects of NSAIDs on the kidney.

Authors:  M D Murray; D C Brater
Journal:  Prog Drug Res       Date:  1997

Review 6.  Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants.

Authors:  R P Giniger; C Buffat; V Millet; U Simeoni
Journal:  J Matern Fetal Neonatal Med       Date:  2007-04

7.  Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.

Authors:  B Van Overmeire; D Touw; P J Schepens; G L Kearns; J N van den Anker
Journal:  Clin Pharmacol Ther       Date:  2001-10       Impact factor: 6.875

Review 8.  Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  A Ohlsson; R Walia; S Shah
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.

Authors:  Eli Heyman; Iris Morag; David Batash; Rimona Keidar; Shaul Baram; Matitiahu Berkovitch
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

10.  Indomethacin and renal impairment in neonates.

Authors:  Satoshi Akima; Alison Kent; Graham J Reynolds; Martin Gallagher; Michael C Falk
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

View more
  10 in total

Review 1.  Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

Authors:  Palmer G Johnston; Maria Gillam-Krakauer; M Paige Fuller; Jeff Reese
Journal:  Clin Perinatol       Date:  2012-01-13       Impact factor: 3.430

Review 2.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  Accidental and iatrogenic causes of acute kidney injury.

Authors:  Katherine Twombley; Michel Baum; Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

Review 4.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

5.  Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus.

Authors:  R Antonucci; L Cuzzolin; A Arceri; A Dessì; V Fanos
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

Review 6.  Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Authors:  Vassilios Fanos; Michele Pusceddu; Angelica Dessì; Maria Antonietta Marcialis
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 7.  Non-dialytic management of acute kidney injury in newborns.

Authors:  Vishal Pandey; Deepak Kumar; Prashant Vijayaraghavan; Tushar Chaturvedi; Rupesh Raina
Journal:  J Renal Inj Prev       Date:  2016-10-29

8.  Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates.

Authors:  Gianluca Terrin; Francesca Conte; Antonella Scipione; Erica Bacchio; Maria Giulia Conti; Rosalia Ferro; Flavia Ventriglia; Mario De Curtis
Journal:  Ital J Pediatr       Date:  2014-02-20       Impact factor: 2.638

9.  Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial.

Authors:  Ashutosh Kumar; Venkataseshan Sundaram; Rahul Yadav; Tejo Pratap Oleti; Srinivas Murki; Arun Krishna; Mangalabharathi Sundaram; Shiv Sajan Saini; Sourabh Dutta
Journal:  BMJ Paediatr Open       Date:  2017-08-11

10.  Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants.

Authors:  Ruben Vaidya; Alexander Knee; Yvonne Paris; Rachana Singh
Journal:  J Perinatol       Date:  2020-09-02       Impact factor: 2.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.